Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcium in the bone matrix refers to inorganic calcium ions incorporated primarily as part of hydroxyapatite crystals \(\mathrm{Ca_{10}(PO_4)_6(OH)_2}\), which are deposited onto an organic collagen scaffold during ossification. This process gives bones their characteristic hardness and compressive strength while serving as the body's principal reservoir for systemic regulation of blood calcium levels. The dynamic balance between deposition (by osteoblasts) and resorption (by osteoclasts) maintains both structural integrity and metabolic needs. While critical for health—and central to diseases like osteoporosis—this entity is not itself considered a classical therapeutic target but rather part of broader physiological pathways involving multiple cell types and regulatory hormones[1][2][3].
These drugs act indirectly by altering cellular processes that control deposition or mobilization of calcium from the bone matrix—primarily through effects on osteoblasts and osteoclasts—not by binding "calcium in the bone matrix" itself.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium in bone matrix.